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Summary Visceral leishmaniasis (VL) remains a public health problem in most countries
bordering the Mediterranean basin. Its diagnosis is challenging and often delayed, as the main
clinical picture is often indistinguishable from that of other infectious and non-infectious
diseases. Herein, we report two unusual cases of VL that presented with several characteristics
of autoimmune hepatitis (AIH). Neither patient had a history of fever, only generalized symptoms
accompanied by polyclonal hypergammaglobulinemia, cytopenias, signs of portal hypertension,
elevated transaminases, and high titers of antinuclear and smooth-muscle autoantibodies (SMA)
with reactivity against filamentous actin (F-actin), which has been recognized as specific to AIH. A
clinical diagnosis of AIH was considered, but a bone marrow biopsy was performed before a liver
biopsy to exclude a primary bone marrow disease. The biopsy led to the diagnosis of VL. The
diagnosis was further confirmed by IgG antibodies against Leishmania spp. using ELISA and PCR-
based assays. Treatment with amphotericin in the first case and pentamidine in the second
(because of a severe reaction to amphotericin) was effective. From the clinical point of view, it
should be emphasized that, in cases with high titers of anti-F-actin AIH-specific SMA accompanied
by polyclonal hypergammaglobulinemia, the possibility of AIH should be cautiously differentiated
from VL; this distinction is of paramount importance because initiation of immunosuppression for
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AIH treatment would be detrimental to a patient with underlying leishmaniasis. Therefore, in such
cases and in areas where the disease is still present, it seems rational to exclude VL before starting
any immunosuppressive therapy.
# 2008 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
e158 K.P. Makaritsis et al.Figure 1 Bone marrow trephine biopsy sections showing Leish-
mania spp. within macrophages (hematoxylin and eosin stain;
original magnification 100).Introduction
Leishmaniasis is still a public health problem in most coun-
tries bordering the Mediterranean basin.1 Its diagnosis is
challenging and often delayed, as the main clinical picture
(fever, generalized symptoms, cytopenias, hypergammaglo-
bulinemia and hepatosplenomegaly) is often indistinguish-
able from that of other infectious and non-infectious
diseases.
Herein, we report two afebrile cases of visceral leishma-
niasis (VL) that presented with several characteristics of
autoimmune hepatitis (AIH). So far, only three cases have
been published of VL presenting as presumed AIH for which
immunosuppression had been initiated.2—4 The importance of
the differential diagnosis between these two conditions is
also described.
Case report
In November 2007, a 74-year-old male presented complaining
of anorexia, abdominal pain, fatigue and weight loss of 15 kg
during the past three months without fever. He suffered from
coronary artery disease, arterial hypertension and diabetes
mellitus. He was an alcohol consumer (30—50 g ethanol/day
for the past 50 years), but not a smoker. Physical examination
revealed petechiae in his legs and hepatosplenomegaly.
Laboratory work-up showed: hemoglobin 9.2 g/dl; leuko-
cytes 1900/ml; platelets 83 000/ml; a high erythrocyte sedi-
mentation rate (ESR, 100 mm/hour); AST (100 IU/L); ALT (109
IU/L); albumin 2.4 g/dl; globulins 5.3 g/dl; serum immuno-
globulin G (IgG) 6700 mg/dl (upper normal limit: 1690 mg/
dl). Serum protein electrophoresis revealed a polyclonal g-
globulin pattern with no monoclonal component detected.
Bence—Jones protein in urine was undetectable. Chest X-ray
was normal. Repeated blood, urine and throat cultures, as
well as antibodies against fungi, brucella and several viruses
(including hepatitis B and C viruses), were negative. Upper
gastrointestinal endoscopy revealed signs of portal gastro-
pathy, suggesting portal hypertension. Seroimmunological
testing gave high positive results for antinuclear antibodies
[ANA 1:640 of discrete speckled pattern by indirect immuno-
fluorescence (IIF); positive titer>1:40), smooth-muscle auto-
antibodies (SMA 1:640; positive titer>1:40) with the
characteristic glomerular/tubular (G/T) pattern in IIF on
rodent multi-organ (kidney-liver-stomach) sections, and
perinuclear staining of anti-neutrophil cytoplasmic antibo-
dies (p-ANCA 1:80; positive titer>1:10). Further testing gave
a high positive result for IgG-specific SMA against filamentous
actin (IgG anti-F-actin SMA 118 units; positive titer>20 units)
on a commercial internationally accepted ELISA (Quanta Lite
Actin IgG assay; Inova Diagnostics, San Diego, CA, USA).5 A
clinical diagnosis of probable AIH type-1 (AIH-1)-related
cirrhosis leading to portal hypertension and hypersplenic
manifestations was made, based on the high IgG concentra-tions, high titers of specific anti-F-actin SMA and the absence
of markers of viral hepatitis.6 Accordingly, a liver biopsy was
planned to confirm the clinical diagnosis.
However, a bone marrow biopsy that was carried out first
to exclude a primary bone marrow disease showed numerous
protozoan parasites (Leishmania spp.) within macrophages
(Figure 1). Subsequently, whole blood testing by PCR using
specific primers for Leishmania spp. and IgG antibodies
against Leishmania spp. in serum by semi-quantitative ELISA
(Leishmania Ab, Cypress Diagnostics, Langdorp, Belgium;
positive sample ratio >1.1) proved to be positive (sample
ratio: 5.2). According to the manufacturer’s instructions, the
sample ratio is calculated by dividing the sample OD = optical
density by the cut-off value obtained by adding 0.15 to the
average OD of two negative controls. For the PCR procedure,
200 ml of peripheral blood, which was collected in EDTA
tubes, was processed for DNA extraction using the QIAmp
DNA mini-kit (QIAGEN, Hilden, Germany) according to the
manufacturer’s instructions. PCR for the amplification of the
small subunit ribosomal RNA gene (ssu-rRNA) of all Leishma-
nia species was carried out using the following primers,
designed by us (GenBank accession number X07773)7: 50-
ttagaccgcaccaagacgaact-30 (sense; nucleotides 1158—1178)
and 50-gatccccaattcatgggtgt-30 (anti-sense; nucleotides
1281—1300). 5 ml of template corresponding to 200 ng of
total DNA was then analyzed in a 50 ml reaction volume
containing 2 mM MgCl2, 50 mM KCl, 10 mM Tris-HCl (pH
8.3), 0.4 mM of each primer, 1.25 U of Taq DNA polymerase
and 0.2 mM dNTP mixture. The reaction was carried out
through cycles in a DNA thermocycler at the following spe-
cifications: initial cycle at 95 8C for 4 min followed by 40
cycles at 94 8C for 30 s, 60 8C for 30 s and 72 8C for 30 s, with a
final extension period at 72 8C for 10 min. A band of approxi-
mately 142 base pairs was obtained, corresponding to the
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tion run contained several negative controls (heat detergent
buffer) and a positive control, including DNA prepared from
promastigotes of Leishmania panamensis strain MHOM/CO/
86/1166.
Therefore, the liver biopsy was postponed and the
patient was then treated for VL with liposomal amphoter-
icin B 3 mg/kg/day on days 1—5, 14 and 21 (total dose
21 mg/kg) intravenously.8 Prompt resolution of his symp-
toms and complete regression of liver and spleen size were
recorded at the end of treatment. Of note, a sharp decrease
in the titers of non-organ-specific autoantibodies was also
recorded, namely, ANA 1:80, SMA 1:80, negative p-ANCA
and IgG anti-F-actin SMA (14.6 units by ELISA). At an eight-
month follow up, there was no recurrence of his symptoms.
When seen in June 2008, he had remained well, with
complete correction of previous anemia, leukopenia and
thrombocytopenia.
In January 2008, an 81-year-old male presented complain-
ing of paroxysmal cough, constipation and malaise for the
past two months, but no fever. His past medical history
included splenectomy due to an accident, appendectomy,
Parkinson’s disease, arterial hypertension and Billroth II
gastrectomy due to peptic ulcer disease. He neither smoked
nor consumed alcohol. On physical examination, the patient
was pale and the liver was palpable 4 cm below the right
costal margin. Laboratory work-up showed: hemoglobin
9.5 g/dl; leukocytes 1300/ml; ESR 93 mm/hour; albumin
2.9 g/dl; globulins 7 g/dl; IgG 5350 mg/dl; rheumatoid fac-
tors (RF) 117 IU/ml (upper normal limit: 15 IU/ml) and
presence of serum cryoglobulins. Serum protein electrophor-
esis revealed a polyclonal g-globulin pattern with no mono-
clonal component detected, and absence of Bence—Jones
protein in urine. Chest X-ray was normal. Clinical and labora-
tory tests showed no evidence of infectious diseases, includ-
ing hepatitis B and C viruses, brucellosis, fungi and
tuberculosis. Seroimmunological testing gave positive results
for ANA and G/T SMA by IIF (1:640 and 1:320, respectively).
Further testing gave a high positive result for IgG-specific
anti-F-actin SMA by ELISA (81.6 units). A clinical diagnosis of
probable AIH-1-related burn out cirrhosis wasmade, based on
recently published simplified criteria for the diagnosis of
AIH.6 As in the previous case, a bone marrow biopsy that
was carried out to exclude a primary bone marrow disease
showed the presence of protozoan parasites (Leishmania
spp.) either extracellular or within bone marrow macro-
phages. Subsequently, both PCR and IgG antibodies in his
serum proved to be positive (sample ratio 4.8) for Leishmania
spp. Treatment with liposomal amphotericin B was started,
but it was discontinued because of a severe anaphylactic
reaction. The patient was then treated efficiently with pen-
tamidine (4 mg/kg every other day for 15 doses totally)
without side effects. He responded rapidly with complete
clinical improvement. Hematological parameters returned to
normal within two months, and RF activity and serum cryo-
globulins disappeared. A sharp decrease in the titers of non-
organ-specific autoantibodies was again recorded 20 days
after the completion of treatment, namely, ANA 1:80, SMA
1:80, p-ANCA 1:20 and negative IgG anti-F-actin SMA (17.3
units by ELISA). When seen in June 2008, he had remained
well, with normal hemoglobin, leukocytes and platelet
counts.Discussion
AIH is a relatively rare chronic necroinflammatory disease of
the liver characterized by hypergammaglobulinemia even in
the absence of cirrhosis, characteristic autoantibodies and an
unfavorable outcome if untreated.5,9 The diagnosis is based
on a combination of demographic, clinical, laboratory (espe-
cially the absence of viral markers of hepatitis B and C),
histological and immunological parameters. The detection of
non-organ-specific and liver-related autoantibodies remains
the hallmark for the diagnosis of the disease.10,11 Further-
more, antibodies against F-actin, particularly in high titers,
have a close relationship with the SMA G/T pattern on IIF, also
known as the microfilament pattern, which is mostly seen in
patients with AIH-1. This suggests F-actin as the predomi-
nant, if not the sole, target of AIH-1-specific SMA reactivity.5
However, recent studies have produced conflicting results
concerning the specificity of these antibodies in AIH-1 diag-
nosis.12 Our cases further support this notion, as both highly
anti-F-actin-specific SMA-positive patients were shown to
suffer from VL.
Interestingly, there was no history of fever in either of our
patients. However, bone marrow biopsies revealed the pre-
sence of the parasite, demonstrating the known propensity of
Leishmania to occur in the reticuloendothelial sytem.1 Nota-
bly, one of our patients presented with subclinical cryoglo-
bulinemia of RF activity, which has been recently recognized
as part of the clinical picture of VL.13 Therefore, both
physician experience and the availability of appropriate
diagnostic and therapeutic tools seem to determine the
outcome of this disease.
The presence of anti-F-actin AIH-1-specific autoantibodies
in VL deserves a brief comment. Evidence exists that soluble
parasite-derived antigens from Leishmania spp. are mito-
genic and trigger production of immunoglobulins with auto-
antibody activity. The release of sequestered neo-antigens
that surround host tissues and cells after cell damage by the
parasite could be another possible explanation, as F-actin is a
ubiquitous antigen in the human body. Finally, in genetically
susceptible patients, molecular mimicry via cross-reactivity
of Leishmania spp. actin cannot be excluded. The absence of
reactivity against F-actin after efficient treatment for VL in
both of our patients further supports these explanations.
The immune response to the infection caused by Leish-
mania spp. includes both T-cell and B-cell activation. How-
ever, the pathogenesis of the disease appears to be related to
T-cell cytotoxicity, and control of VL depends on the magni-
tude of T helper 1 (Th1) and multicytokine responses early in
the course of the infection.14 Indeed, it has been shown
during progressive infection in mice that Th2 CD4+ T cells
expand and secrete interleukin-4, resulting in polyclonal B-
cell activation. Later on, in fully established VL, a cellular
anergy is established. Inappropriate antigen presentation
and communication between the antigen-presenting cells
and T cells, as well as the induction of intereukin-10 and
interleukin-4, might be the reason for this anergy.14 The
absence of fever in our two elderly cases might be due to
the above-mentioned dysregulation of the immune system
caused by the infection and also to the known decreased
capacity of cytotoxic responses during senescence.
From the clinical point of view, it should be emphasized
that, in cases with high titers of anti-F-actin AIH-1-specific
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bulinemia, transaminasemia and hepatosplenomegaly, the
possibility of AIH-1 should be cautiously differentiated from
VL. This distinction is of paramount importance because
initiation of immunosuppression for AIH-1 treatment will
be detrimental to a patient with underlying leishmaniasis.
Therefore, in such cases and in areas where the disease is still
present, it seems rational to exclude VL before starting any
immunosuppressive therapy. Perhaps the very high levels of
g-globulins, although not a surprising finding in AIH, could be
used as a surrogate marker to confirm VL in these unusual
cases. The use of rapid and specific molecular-based assays,
such as PCR, could also be helpful to achieve a correct and
timely diagnosis.7,15
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